Medicare Enrolled
Dr. Benjamin Martin, MD
Urology Physician · Gahanna, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. Benjamin Martin is an urology physician in Gahanna, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martin performed 11,717 Medicare services across 1,631 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martin received a total of $214,281 from 46 pharmaceutical and/or device companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in OH
$214,281 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,717
Medicare services
Top 2% in OH for urology physician
1,631
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~586 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,220 | $19 | $62 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,200 | $0 | $2 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
461 | $47 | $184 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 445 | $135 | $602 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
379 | $82 | $290 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
341 | $8 | $32 |
| PSA test (prostate cancer screening) | 271 | $18 | $70 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
246 | $44 | $181 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
236 | $124 | $310 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
164 | $35 | $140 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
86 | $25 | $99 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $58 | $203 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
80 | $24 | $84 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $11 | $49 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
50 | $51 | $204 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
43 | $18 | $73 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
40 | $55 | $460 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $106 | $426 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
34 | $7 | $145 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
34 | $34 | $139 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
26 | $3 | $7 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
20 | $95 | $387 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
18 | $17 | $68 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $94 | $443 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
17 | $116 | $929 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
17 | $135 | $1,498 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
15 | $175 | $772 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
15 | $52 | $268 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
14 | $24 | $96 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $121 | $509 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
12 | $4 | $112 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
12 | $78 | $494 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $56 | $257 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$214,281
Total received (2018-2024)
Avg $30,612/year across 7 years
Top 1% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155,331 (72.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,525 (23.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,425 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,968
2023
$39,703
2022
$52,608
2021
$19,364
2020
$21,457
2019
$26,005
2018
$36,176
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$9,746
Bayer Healthcare Pharmaceuticals Inc.
$5,330
UROGEN PHARMA, INC.
$1,717
Janssen Biotech, Inc.
$535
Telix Pharmaceuticals
$450
PROGENICS PHARMACEUTICALS, INC.
$185
AngioDynamics, Inc.
$175
Astellas Pharma US Inc
$149
Endo USA, Inc.
$149
Sumitomo Pharma America, Inc.
$110
Novartis Pharmaceuticals Corporation
$75
PFIZER INC.
$74
Myriad Genetic Laboratories, Inc.
$73
AstraZeneca Pharmaceuticals LP
$55
Ferring Pharmaceuticals Inc.
$52
ABBVIE INC.
$25
Janssen Scientific Affairs, LLC
$21
Tolmar, Inc.
$17
Endo Pharmaceuticals Inc.
$17
ACCORD HEALTHCARE, INC.
$15
Top 3 companies account for 88.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$47,525
Dendreon Pharmaceuticals LLC
$40,381
Janssen Biotech, Inc.
$30,696
Bayer Healthcare Pharmaceuticals Inc.
$19,863
Astellas Pharma US Inc
$18,592
Janssen Scientific Affairs, LLC
$17,815
Myovant Sciences Inc.
$14,102
PFIZER INC.
$6,373
Ferring Pharmaceuticals Inc.
$3,951
AstraZeneca Pharmaceuticals LP
$3,266
AngioDynamics, Inc.
$3,035
Clovis Oncology, Inc.
$2,962
UROGEN PHARMA, INC.
$1,741
Blue Earth Diagnostics Limited
$1,126
Telix Pharmaceuticals
$450
GENZYME CORPORATION
$246
Endo Pharmaceuticals Inc.
$215
Amgen Inc.
$203
Progenics Pharmaceuticals, Inc.
$198
PROGENICS PHARMACEUTICALS, INC.
$185
Sumitomo Pharma America, Inc.
$180
CONMED Corporation
$167
Endo USA, Inc.
$149
UroGen Pharma, Inc.
$100
Novartis Pharmaceuticals Corporation
$99
Myriad Genetic Laboratories, Inc.
$73
TOLMAR Pharmaceuticals, Inc.
$65
Cook Medical LLC
$57
UROVANT SCIENCES INC
$54
Boston Scientific Corporation
$48
MEDIVATION FIELD SOLUTIONS LLC
$33
AbbVie Inc.
$32
Tolmar, Inc.
$32
AbbVie, Inc.
$32
ConvaTec Inc.
$28
Coloplast Corp
$25
ABBVIE INC.
$25
E.R. Squibb & Sons, L.L.C.
$25
Accord Healthcare, Inc.
$23
180 Medical, Inc.
$22
Foundation Medicine, Inc.
$20
Sun Pharmaceutical Industries Inc.
$17
ACCORD HEALTHCARE, INC.
$15
Verity Pharmaceuticals Inc.
$14
PROCEPT BioRobotics Corporation
$14
Travere Therapeutics, Inc.
$11
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BALVERSA · BOTOX · CAMCEVI · CONTINENCE CARE · COOK MEDICAL STENTS · EDEX · ELIGARD · ENZALUTAMIDE · ERLEADA · Erleada · GEMTESA · GENTLECATH · ILLUCCIX · JATENZO · JELMYTO · JEVTANA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · MYRBETRIQ · Myrbetriq · NANOKNIFE · Non-Covered · Nubeqa · OPDIVO · ORGOVYX · PIPELINE · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolia · RUBRACA · Rezum Generator · SPEEDICATH · SUTENT · TALZENNA · TOVIAZ · Thiola · Trelstar · VESICARE · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in OH.
Geographic Context
Urology physicians within 10 mi
99
Per 100K population
7.5
County median income
$73,795
Nearest hospital
MOUNT CARMEL NEW ALBANY SURGICAL HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martin is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Martin performed 5,220 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $214,281 from 46 companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other urology physicians in Gahanna?
Dr. Martin's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Gahanna
Browse urology physicians in Gahanna ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology